Sanuwave Health Inc.
SNWV Healthcare Medical Devices
Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024. In the quarter to June 2026, revenue fell 3.13%, EPS fell 224.2%, free cash flow grew 86.8% and total debt fell 28.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow SNWV
Sanuwave Health Inc. (SNWV) EV/Sales
As of 16 October 2026, Sanuwave Health Inc. (SNWV) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 1.0× (September 2026) to 10.3× (August 2025); the current reading is higher than 7% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.0× | 67.02% |
| FY2024 | 3.6× | 66.39% |
| FY2023 | 2.2× | 0.00% |
| FY2022 | 2.2× | 0.00% |
| FY2021 | 2.2× | 0.00% |
| FY2020 | 2.2× | 0.00% |
| FY2019 | 2.2× | 0.00% |
| FY2018 | 2.2× | 0.00% |
| FY2017 | 2.2× | 0.00% |
| FY2016 | 2.2× | 0.00% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.2× | (39.05%) |
| Mar 2026 | 3.6× | (40.76%) |
| Dec 2025 | 6.0× | (25.93%) |
| Sep 2025 | 8.1× | 6.13% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| TLIS Talis Biomedical Corporation compare | −55.3× |
| NNOX Nano-X Imaging Ltd. compare | 0.4× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| RPID Rapid Micro Biosystems, Inc. compare | 1.0× |
| TELA TELA Bio, Inc. compare | 1.1× |
| SNWV Sanuwave Health Inc. | 1.2× |
| SRTS Sensus Healthcare, Inc. compare | 2.1× |
| MDAI Spectral AI, Inc. compare | 3.0× |
| COCH Envoy Medical, Inc. compare | 390× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)